NuSkin Enterprises NUS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.3%+1.7pp | 69.4%+1.2pp | 67.2%-3.5pp | 67.2%-0.3pp | 67.6%-0.9pp | |
| Operating margin | 5.5%+15.7pp | 4.4%+13.2pp | -0.7%+4.0pp | -0.9%+6.0pp | -10.1%-12.3pp | |
| Net margin | 3.8%+6.1pp | 10.8%+19.3pp | 7%+12.8pp | 6.2%+14.3pp | -2.3%-2.1pp | |
| EBITDA margin | 9%+15.3pp | 7.9%+12.7pp | 2.9%+3.5pp | 2.9%+5.8pp | -6.2%-12.2pp | |
| Free cash flow margin | 2.9%-1.0pp | 3.1%-1.0pp | 3.4%-1.7pp | 3.6%-2.2pp | 3.9%-0.5pp | |
| Returns | ||||||
| Return on equity | 7%+12.0pp | 22%+41.9pp | 14.5%+28.0pp | 13.7%+32.5pp | -4.9%-4.5pp | |
| Return on assets | 3.9%+6.4pp | 11.1%+20.1pp | 7.3%+13.4pp | 6.7%+15.2pp | -2.5%-2.3pp | |
| Return on invested capital | 7.6%+24.1pp | 5.9%+20.2pp | -1%+6.5pp | -1.3%+9.8pp | -16.5%-18.2pp | |
| Efficiency | ||||||
| Asset turnover | 1×0.0× | 1×0.0× | 1×0.0× | 1.1×0.0× | 1.1×0.0× | |
| Inventory turnover | 2.4×0.0× | 2.5×+0.1× | 2.4×+0.5× | 2.5×+0.6× | 2.4×+0.5× | |
| Liquidity | ||||||
| Current ratio | 2×0.0× | 2.1×+0.3× | 2.2×+0.2× | 2×-0.1× | 2×-0.1× | |
| Quick ratio | 1.3×0.0× | 1.4×+0.2× | 1.5×+0.3× | 1.4×0.0× | 1.3×+0.1× | |
| Cash ratio | 0.8×0.0× | 0.9×+0.3× | 1×+0.3× | 0.9×+0.2× | 0.8×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×-0.1× | 0.4×-0.4× | 0.4×-0.4× | 0.4×-0.4× | 0.4×-0.3× | |
| Debt-to-assets | 0.2×0.0× | 0.2×-0.1× | 0.2×-0.1× | 0.2×-0.1× | 0.2×-0.1× | |
| Net debt / EBITDA | 0.8×— | —— | —— | —— | —— | |
| Interest coverage | 5.3×+13.0× | 4.7×+10.5× | -0.7×+2.3× | -0.8×+3.6× | -7.6×-9.1× | |
| Per Share | ||||||
| Book value per share | $16.07+7.3% | $16.01+22.0% | $15.90+11.8% | $15.91+15.2% | $14.98-8.4% | |
| Valuation | ||||||
| Market capitalization | $256.35M-38.2% | $468.98M+36.9% | $603.38M+64.8% | $383.44M-26.6% | $360.99M-47.2% | |
| Enterprise value | $348.19M-25.7% | $538.99M-15.1% | $671.86M+0.4% | $458.46M-46.4% | $487.78M-54.0% | |
| Price / earnings | 4.5×+0.6× | —— | —— | —— | —— | |
| Price / sales | 0.2×-0.1× | 0.3×+0.1× | 0.4×+0.2× | 0.2×0.0× | 0.2×-0.1× | |
| Price / book | 0.3×-0.2× | 0.6×+0.1× | 0.8×+0.2× | 0.5×-0.3× | 0.5×-0.4× | |
| EV / EBITDA | 2.7×-7.3× | —— | —— | —— | —— | |
| EV / sales | 0.2×0.0× | 0.4×0.0× | 0.4×+0.1× | 0.3×-0.2× | 0.3×-0.3× | |
| Free cash flow yield | 17.1%+2.2pp | 9.8%-10.7pp | 8.8%-15.9pp | 15.3%-5.2pp | 18.3%+5.9pp | |
| Earnings yield | 22.4%-3.2pp | 34.2%+77.0pp | 18.2%+46.3pp | 26.3%+54.7pp | -10.7%-10.2pp | |
| Dividend yield | 4.8%+1.8pp | 2.5%-1.0pp | 2%-5.7pp | 3.1%-5.5pp | 3.3%-5.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do NuSkin Enterprises's ratios come from?
- Every ratio is computed from NuSkin Enterprises's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.